Diversity in Clinical Pharmacology: A Call to Action.

Diversity in Clinical Pharmacology: A Call to Action.
复制标题

DOI:
10.1002/cpt.2852
复制
发表时间:
2023-03
影响因子:
6.7
通讯作者:
Dresser, Mark
Dresser, Mark
中科院分区:
医学2区
文献类型:
--
作者:
Brown, Karen;Etrouth, Shravani;Jayachandran, Priya;Moore, Jason;Oni-Orisan, Akinyemi;Vasist, Lakshmi;Zheng, Songmao;Zhou, Zhu;Dresser, Mark

文献摘要

参考文献

被引文献

相似文献

对于临床药理学界来说,我们早就应该在工作的各个方面优先考虑多样性、公平性和包容性。临床研究日益多样化将加深我们对患者群体细微差别的了解,并有助于改善所有患者的治疗结果。培养包容性和多元化的员工队伍将带来更广阔的视野,可以更好地为关键决策提供信息,并创造每个人都能蓬勃发展的工作环境。在此号召性用语中,我们邀请您加入我们。
Prioritization of diversity, equity, and inclusion in all facets of our work is long overdue for the clinical pharmacology community. Increasing diversity in clinical research will deepen our understanding of nuanced patient populations and help improve all patient outcomes. Fostering an inclusive and diverse workforce will lead to broader perspectives that can better inform critical decisions and create work environments where everyone can thrive. In this call to action, we invite you to join us.
DOI: 10.1038/s41591-021-01672-4
发表时间: 2022-03
期刊: Nature medicine
影响因子: 82.9
作者:
Fatumo S;Chikowore T;Choudhury A;Ayub M;Martin AR;Kuchenbaecker K
通讯作者: Kuchenbaecker K
DOI: 10.1016/j.phrs.2022.106087
发表时间: 2022-01-17
影响因子: 9.3
作者:
Siamoglou, Stavroula;Koromina, Maria;Patrinos, George P.
通讯作者: Patrinos, George P.